Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

T3 glottic cancer: an analysis of dose time-volume factors

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
This report analyzes dose-time-volume factors in 112 patients with T3N0M0 glottic cancer who were treated with radical radiotherapy with surgery for salvage between 1963 and 1977. 55% of the patients are alive and well 5 years following treatment; 26% died of glottic cancer and 19% died of intercurrent disease. In the 1965 to 1969 time period, 31% died of tumor as compared to 16% in the 1975 to 1977 time period. Overall local control by radiotherapy was 51%; 2/3 of the failures were surgically salvaged. 44% were locally controlled by radiotherapy in the 1965 to 1969 time period and 57% in the 1975 to 1977 time period. Analysis of dose-time-volume factors reveals that the optimal dose is greater than 1700 ret and a minimal volume of 6 x 8 cm should be used. A dose-cure curve for T3 glottic cancer is constructed and compared with the dose complication curve for the larynx and the dose-cure curve for T1N0M0 glottic cancer. A comparison of cure rates between 112 patients treated with radical radiotherapy and surgery for salvage versus 28 patients treated with combined pre-operative irradiation and surgery reveals no difference in the proportion of patients who died of glottic cancer or in the number of patients alive at 5 years following treatment.
Research Organization:
Princess Margaret Hospital, Toronto, Ontario
OSTI ID:
6854468
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Vol. 6:6; ISSN IOBPD
Country of Publication:
United States
Language:
English